|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1668 SEK | +4.38% |
|
+8.31% | -25.87% |
| 07/05 | Cell Impact AB Signs Main Agreement with F.C.C | CI |
| 26/04 | Cell Impact AB Signs Agreement Valued At SEK 3.2 Million | CI |
Cell Impact AB (publ) reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported sales was SEK 0.838 million compared to SEK 18.03 million a year ago. Revenue was SEK 1.08 million compared to SEK 29.8 million a year ago.
Net loss was SEK 37.52 million compared to SEK 28.93 million a year ago. Basic loss per share from continuing operations was SEK 0.18 compared to SEK 0.38 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -25.87% | 9.05M | |
| +75.89% | 4.27B | |
| +7.06% | 2.1B | |
| +11.74% | 2.06B | |
| +0.62% | 2.01B | |
| -5.86% | 1.46B | |
| -0.32% | 1.45B | |
| +20.02% | 1.39B | |
| -28.10% | 1.29B | |
| -15.35% | 1.25B |
CELL IMPACT AB 